This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. This represents the first FDA clearance for Imricor Medical Systems. "It’s an exciting achievement and a date to be noted and remembered," CEO Steve Wedan said in a statement. | | |
|
The two vendors involved say supplies of PYP and HDP could be disrupted for months. The two vendors involved say supplies of PYP and HDP could be disrupted for months. | | |
|
Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology. Researchers tracked data from more than 400,00 patients, sharing their findings in JAMA Cardiology. | | |
|
The traveling clinician pleaded guilty to three counts of second-degree assault. All other charges were dropped, and he was released from jail. According to his attorney, the cardiologist agreed to this plea agreement to "get on with his life." The traveling clinician pleaded guilty to three counts of second-degree assault. All other charges were dropped, and he was released from jail. According to his attorney, the cardiologist agreed to this plea agreement to "get on with his life." | | |
|
|
The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation. The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation. | | |
|
A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.” A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.” | | |
|
Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis. Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis. | | |
|
The device at the heart of this transaction is the PerQseal Elite system, a fully bioabsorbable patch for percutaneous vessel closure. The technology has already gained key approvals in Europe. The device at the heart of this transaction is the PerQseal Elite system, a fully bioabsorbable patch for percutaneous vessel closure. The technology has already gained key approvals in Europe. | | |
|
SCCT has made it a priority to help clinicians from all over the world learn more about CCTA as the modality continues to transform patient care. SCCT has made it a priority to help clinicians from all over the world learn more about CCTA as the modality continues to transform patient care. | | |
|
|
Cardiologists now have a new tool to assist with PDA closure in these vulnerable patients. Cardiologists now have a new tool to assist with PDA closure in these vulnerable patients. | | |
|
Cardiology has largely shifted to hospital-employed models, driven by reimbursement compression and evolving physician priorities. This has created challenges as well as opportunities. Cardiology has largely shifted to hospital-employed models, driven by reimbursement compression and evolving physician priorities. This has created challenges as well as opportunities. | | |
|
The new deep learning algorithm is capable of detecting signs of coronary microvascular dysfunction in seconds. The new deep learning algorithm is capable of detecting signs of coronary microvascular dysfunction in seconds. | | |
|
|
People diagnosed with cancer in the 2020s have a much greater chance of beating the disease than they would have had in decades past. People diagnosed with cancer in the 2020s have a much greater chance of beating the disease than they would have had in decades past. | | |
|
The entrepreneur took to X this week to tout his accomplishment, which was achieved with the help of Anthropic’s Claude AI. The entrepreneur took to X this week to tout his accomplishment, which was achieved with the help of Anthropic’s Claude AI. | | |
|
